Friday, August 21, 2015 11:15:40 PM
This was necessary, as the previous authorization was maxed -- yet the company had 30M or so convertible preferred shares outstanding and had committed 120M shares (40% of the shares then O/S) to the two principal officers. So 50% increase in authorization was needed for existing commitments, and the company in the past has used common shares to fund professional services, advertising, and business development activities.
Recent PRs have not resulted in dramatic increases in share price level, perhaps because of company track record on execution.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM